SEC Tracker
Get the app

Editas Medicine EDIT

Editas Medicine: annual report for the year ended Dec 31, 2019

Form
10-K
Filed
Period
Importance
Notable
Document
10-K
Exhibit 10.13
Material contract
Exhibit 10.14
Material contract
Exhibit 10.15
Material contract
Exhibit 10.16
Material contract
Exhibit 10.20
Material contract
Exhibit 10.21
Material contract
Exhibit 10.25
Material contract
Exhibit 10.30
Material contract
Exhibit 10.31
Material contract

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Editas Medicine files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Merus MRUS
  2. Palvella Therapeutics PVLA public float $197M, Jun 30, 2025
  3. Esperion Therapeutics ESPR public float $198M, Jun 30, 2025
  4. Rezolute RZLT public float $204M, Dec 31, 2025
  5. Cardiff Oncology CRDF public float $205M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.